Target intelligence / Profile preview

Class A beta-lactamases and penicillin-binding proteins in Acinetobacter species (Class A BLs and PBPs (Acinetobacter))

Target
Class A BLs and PBPs (Acinetobacter)
Molecular classification
Enzyme, Hydrolase, Transferase, Cell wall synthesis protein
01

Overview

This target profile represents a critical dual-mechanism approach for treating infections caused by Acinetobacter species, particularly Acinetobacter baumannii (Papp-Wallace et al., 2023). Class A beta-lactamases are serine-based enzymes produced by these bacteria that hydrolyze and inactivate various beta-lactam antibiotics, including penicillins and cephalosporins (Bush & Bradford, 2020). Penicillin-binding proteins (PBPs), specifically PBP1a, PBP1b, and PBP3, are essential membrane-associated enzymes involved in the final stages of peptidoglycan synthesis, which is necessary for maintaining bacterial cell wall integrity (Penwell et al., 2015). In Acinetobacter, certain drugs like sulbactam act as both a beta-lactamase inhibitor and a direct antibacterial agent by binding to these specific PBPs (Penwell et al., 2015). The combination of PBP-targeting agents with novel beta-lactamase inhibitors like durlobactam restores antibiotic efficacy by protecting the drug from enzymatic degradation by Class A, C, and D enzymes (Papp-Wallace et al., 2023). This synergistic strategy is vital for addressing multi-drug resistant (MDR) Acinetobacter infections, which are often associated with high mortality rates in hospital settings. Targeting these proteins simultaneously overcomes the primary resistance mechanisms employed by the pathogen, such as enzymatic inactivation and target site modification. Clinical focus on these targets has led to the development of specialized therapies like sulbactam-durlobactam, specifically designed for carbapenem-resistant Acinetobacter baumannii (CRAB).

Other names
Ambler Class A beta-lactamasesPenicillin-binding proteinsPBPsSerine beta-lactamasesAcinetobacter baumannii PBPsPBP1aPBP1bPBP3ftsI
02

Mechanism of action

Inhibition of bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs) and simultaneous inhibition of Class A beta-lactamases to prevent antibiotic degradation (Penwell et al., 2015; Papp-Wallace et al., 2023).

03

Biological functions

Cell wall peptidoglycan biosynthesisAntibiotic resistanceHydrolysis of beta-lactam antibioticsPeptidoglycan cross-linking
04

Disease associations

InfectionBacteremiaPneumoniaUrinary tract infectionMeningitis
05

Safety considerations

Hypersensitivity reactionsClostridioides difficile-associated diarrheaDevelopment of antimicrobial resistanceNeurotoxicityLiver enzyme elevations
06

Interacting drugs

Sulbactam

7 more in the full profile.

07

Biomarkers

blaTEM geneblaSHV geneblaKPC geneblaPER geneblaVEB genePBP3 (ftsI) mutationsMinimum Inhibitory Concentration (MIC)

Beyond the preview

Go deeper on Class A beta-lactamases and penicillin-binding proteins in Acinetobacter species (Class A BLs and PBPs (Acinetobacter)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class A beta-lactamases and penicillin-binding proteins in Acinetobacter species (Class A BLs and PBPs (Acinetobacter)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call